SecBot SecBot

Reducing Hereditary Cancer Act

H.R. 1526 Rep. Debbie Wasserman Schultz (D-FL-25) In committee
Bill text PDF
  1. Introduced Mar 9
  2. Committee Mar 9
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Mar 9, 2023Next: House vote
680d ago Dec 17, 2024: Referred to the Subcommittee on Health.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 3 filings
Subscribe to see spend
Member trades
1trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Medical Devices & Healthcare 2
Search all 2 companies, their asks and price moves Subscribe

Summary

Reducing Hereditary Cancer Act

Full summary1 paragraphs

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Library of Congress summary, Mar 9, 2023

Summary versions
  • Introduced in HouseMar 9, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.